§ Mr. Wigleyasked the Secretary of State for Wales if he will take steps to arrange for the first report of the Welsh cancer registry, entitled "Cancer Registration in Wales 1974–1978," to be republished in a form which analyses the data in espect of wards and enumeration districts.
§ Mr. Mark RobinsonThere are no plans to republish the first report of the Welsh cancer registry in the form requested.
§ Mr. Wigleyasked the Secretary of State for Wales how many women in Wales were diagnosed during 1985 to be suffering from breast cancer; and how many died from breast cancer during 1985.
§ Mr. Mark RobinsonThe latest available information is given in the following table:
Year of registration/death 1983 1984 Registration of newly diagnosed cases of breast cancer 1,331 —* Number of deaths due to breast cancer 748 806 * Not available.
§ Mr. Wigleyasked the Secretary of State for Wales what progress has been made by his Department in improving services for cancer patients in northern Wales.
All Employees in Employment Part-time Full-time Male employees Female employees June 1978 Clwyd 23,800 103,900 78,600 49,100 Dyfed 18,300 87,200 65,600 39,800 Gwent 27,400 139,600 104,000 63,000 Gwynedd 12,900 56,900 41,700 28,100 Mid-Glamorgan 30,800 155,400 109,900 76,300 Powys 6,300 23,400 17,900 11,800 South Glamorgan 32,800 135,900 96,000 72,700 West Glamorgan 25,400 135,400 99,500 61,300 Wales 177,800 837,600 613,200 402,100
480W
All Employees in Employment Part-time Full-time Male employees Female employees September 1981 Clwyd 24,000 88,800 65,900 46,900 Dyfed 19,300 80,000 61,100 38,200 Gwent 27,200 123,000 89,700 60,500 Gwynedd 14,400 52,700 38,600 28,500 Mid Glamorgan 27,400 135,500 96,000 66,900 Powys 6,600 22,300 16,900 12,100 South Glamorgan 33,300 128,700 90,400 71,600 West Glamorgan 28,900 114,900 82,900 61,000 Wales 181,300 745,900 541,600 385,600
§ Mr. Mark RobinsonA departmental working party was appointed to report to my right hon. Friend the Secretary of State on regional services in North Wales, including services for cancer patients. Its recommendations are presently being considered.